Colorectal cancermesoporousstimuli sensitivedrug targetingnanoparticlesnanomedicine.1.Rahmani F, Zandigohar M, Safavi P, et al. The interplay between noncoding RNAs and p21 signaling in gastrointestinal cancer: From tumorigenesis to metastasis. Curr Pharm Des 2023; 29(10): 766-76. doi: 10.2174/1381612829666230306123455 PMID: 368768352.Sharma N, Kumari R, Karwasra R, Khanna K. Colon cancer and their targeting approaches through nanocarriers: A review. Asian Pac J Trop Biomed 2023; 13(3): 104-11. doi: 10.4103/2221-1691.3722833.Hofmann B. Ethical issues with colorectal cancer screening-a systematic review. J Eval Clin Pract 2017; 23(3): 631-41. doi: 10.1111/jep.12690 PMID: 280260764.Marin JJ, Romero MR, Blazquez AG, Herraez E, Keck E, Briz O. Importance and limitations of chemotherapy among the available treatments for gastrointestinal tumours. Anticancer Agents Med Chem 2009; 9(2): 162-84. doi: 10.2174/1871520097873138285.Watermann A, Brieger J. Mesoporous silica nanoparticles as drug delivery vehicles in cancer. Nanomaterials (Basel) 2017; 7(7): 189. doi: 10.3390/nano70701896.Meng J, Wang ZG, Zhao X, et al. Silica nanoparticle design for colorectal cancer treatment: Recent progress and clinical potential. World J Clin Oncol 2024; 15(6): 667-73. doi: 10.5306/wjco.v15.i6.667 PMID: 389468307.Feng W, Zhou X, He C, et al. Polyelectrolyte multilayer functionalized mesoporous silica nanoparticles for pH-responsive drug delivery: Layer thickness-dependent release profiles and biocompatibility. J Mater Chem B Mater Biol Med 2013; 1(43): 5886-98. doi: 10.1039/c3tb21193b PMID: 322610558.Baeza A, Colilla M, Vallet-Regí M. Advances in mesoporous silica nanoparticles for targeted stimuli-responsive drug delivery. Expert Opin Drug Deliv 2015; 12(2): 319-37. doi: 10.1517/17425247.2014.953051 PMID: 254218989.Narayan R, Gadag S, Cheruku SP, et al. Chitosan-glucuronic acid conjugate coated mesoporous silica nanoparticles: A smart pH-responsive and receptor-targeted system for colorectal cancer therapy. Carbohydr Polym 2021; 261: 117893. doi: 10.1016/j.carbpol.2021.117893 PMID: 3376637810.Thirupathi K, Santhamoorthy M, Radhakrishnan S, et al. Thermosensitive polymer-modified mesoporous silica for pH and temperature-responsive drug delivery. Pharmaceutics 2023; 15(3): 795. doi: 10.3390/pharmaceutics1503079511.Zou Z, He X, He D, et al. Programmed packaging of mesoporous silica nanocarriers for matrix metalloprotease 2-triggered tumor targeting and release. Biomaterials 2015; 58: 35-45. doi: 10.1016/j.biomaterials.2015.04.034 PMID: 2594178012.Yang X, Liu X, Liu Z, Pu F, Ren J, Qu X. Near-infrared light-triggered, targeted drug delivery to cancer cells by aptamer gated nanovehicles. Adv Mater 2012; 24(21): 2890-5. doi: 10.1002/adma.20110479713.Al-Mosawi AKM, Bahrami AR, Nekooei S, Saljooghi AS, Matin MM. Using magnetic mesoporous silica nanoparticles armed with EpCAM aptamer as an efficient platform for specific delivery of 5-fluorouracil to colorectal cancer cells. Front Bioeng Biotechnol 2023; 10: 1095837.14.Iranpour S, Bahrami AR, Nekooei S, Sh Saljooghi A, Matin MM. Improving anti-cancer drug delivery performance of magnetic mesoporous silica nanocarriers for more efficient colorectal cancer therapy. J Nanobiotechnol 2021; 19(1): 314. doi: 10.1186/s12951-021-01056-3 PMID: 3464185715.He X, Zhao Y, He D, Wang K, Xu F, Tang J. ATP-responsive controlled release system using aptamer-functionalized mesoporous silica nanoparticles. Langmuir 2012; 28(35): 12909-15. doi: 10.1021/la302767b PMID: 22889263